LE cell

An LE cell (Lupus Erythematosus cell) is a neutrophil or macrophage that has phagocytized (engulfed) the denatured nuclear material of another cell.[1] The denatured material is an absorbed hematoxylin body (also called an LE body).[2]

Microphotograph of a macrophage that has phagocytized a lymphocyte (LE cell). May Grünwald Giemsa stain.

They are a characteristic of lupus erythematosus,[3] but also found in similar connective tissue disorders or some autoimmune diseases like in severe rheumatoid arthritis. LE cells can be observed in drug-induced lupus, for example, following treatment with methyldopa.[4]

The LE cell was discovered in bone marrow in 1948 by Malcolm McCallum Hargraves (1903–1982), a Physician and Practicing Histologist at the Mayo Clinic.[5] Hargraves may have gained priority by suppressing a publication draft of John R. Haserick, who credits Dr. Dorothy Sundberg, chief hematologist at the University of Minnesota Hospitals, with first identifying LE cells. [6]

Classically, the LE cell is analyzed microscopically, but it is also possible to investigate this phenomenon by flow cytometry.[7]

LE cells shouldn't be confused with Tart cells which have engulfed nuclear material, but with a visible chromatin rather than homogeneous appearance. [8]

References

"Medical Definition of LE CELL". www.merriam-webster.com.
similima.com > Autoimmunity Archived 2011-07-27 at the Wayback Machine By Muhammed Muneer. Retrieved Mars 2011
"Archived copy". Archived from the original on 2012-03-08. Retrieved 2010-06-28.CS1 maint: archived copy as title (link)
Cheesbrough, Monica (2000-10-26). District Laboratory Practice in Tropical Countries. Cambridge University Press. ISBN 9780521665452.
Hargraves M, Richmond H, Morton R. Presentation of two bone marrow components, the tart cell and the LE cell. Mayo Clin Proc 1948;27:25–28.
https://www.derm101.com/dpc-archive/april-june-2000-volume-6-no-2/dpc0602a20-discovery-of-the-le-factor/
Böhm, Ingrid (1 January 2004). "Flow Cytometric Analysis of the LE Cell Phenomenon". Autoimmunity. 37 (1): 37–44. doi:10.1080/08916930310001630325. PMID 15115310.
Li, Qing Kay; Khalbuss, Walid E. (2015). Diagnostic Cytopathology Board Review and Self-Assessment. Springer, New York, NY. p. 179. doi:10.1007/978-1-4939-1477-7_2. ISBN 9781493914760.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] "Medical Definition of LE CELL". www.merriam-webster.com.

[2] similima.com > Autoimmunity Archived 2011-07-27 at the Wayback Machine By Muhammed Muneer. Retrieved Mars 2011

[3] "Archived copy". Archived from the original on 2012-03-08. Retrieved 2010-06-28.CS1 maint: archived copy as title (link)

[4] Cheesbrough, Monica (2000-10-26). District Laboratory Practice in Tropical Countries. Cambridge University Press. ISBN 9780521665452.

[5] Hargraves M, Richmond H, Morton R. Presentation of two bone marrow components, the tart cell and the LE cell. Mayo Clin Proc 1948;27:25–28.

[6] ttps://www.derm101.com/dpc-archive/april-june-2000-volume-6-no-2/dpc0602a20-discovery-of-the-le-factor/

[pmid15115310-7] Böhm, Ingrid (1 January 2004). "Flow Cytometric Analysis of the LE Cell Phenomenon". Autoimmunity. 37 (1): 37–44. doi:10.1080/08916930310001630325. PMID 15115310.

[8] Li, Qing Kay; Khalbuss, Walid E. (2015). Diagnostic Cytopathology Board Review and Self-Assessment. Springer, New York, NY. p. 179. doi:10.1007/978-1-4939-1477-7_2. ISBN 9781493914760.